Skip to main content

Table 2 Body weights, food intakes, organ weights and plasma lipid levels.

From: Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes

  Control C16:0 C16:1
Initial body weight (g) 30.0 ± 0.3 30.1 ± 0.3 30.8 ± 0.4
Final body weight (g) 36.7 ± 0.5a 35.3 ± 0.7a 32.1 ± 1.1b
Food intake (g/day) 6.1 ± 0.1a 5.8 ± 0.2a 5.1 ± 0.3b
Organ weights    
   Liver (mg/g BW) 46.9 ± 1.3a 46.3 ± 1.3a 40.2 ± 0.9b
   Pancreas (mg/g BW) 9.6 ± 0.2a 10.2 ± 0.2a 11.2 ± 0.3b
   Mesenteric WAT (mg/g BW) 21.2 ± 0.9 21.1 ± 0.4 19.1 ± 1.2
   BAT (mg/g BW) 7.2 ± 0.5 7.1 ± 0.4 7.6 ± 0.4
   Skeletal muscle (mg/g BW) 8.8 ± 0.3 8.6 ± 0.3 9.1 ± 0.5
Plasma lipid parameters    
   Triglyceride (mg/dL) 259.2 ± 21.1a 237.3 ± 15.7a 129.1 ± 23.7b
   Total cholesterol (mg/dL) 112.7 ± 8.2 99.4 ± 5.9 109.7 ± 4.6
   Free fatty acid (mEq/L) 0.49 ± 0.03 0.48 ± 0.02 0.48 ± 0.03
  1. KK-Ay mice were orally administrated vehicle (control), 300 mg/kg of palmitic acid, or 300 mg/kg palmitoleic acid on a daily basis for 4 weeks. Values are means ± SE, n = 10. Means in a row with superscripts without common letter are different, p < 0.05. C16:0, palmitic acid; C16:1, palmitoleic acid; BW, body weight; WAT, white adipose tissue; BAT, brown adipose tissue.